Devonian Health Group Inc.
DVHGF · OTC
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Revenue | $1,052 | $923 | $7,363 | $8,828 |
| % Growth | 14% | -87.5% | -16.6% | – |
| Cost of Goods Sold | $522 | $60 | $4,667 | $6,215 |
| Gross Profit | $530 | $863 | $2,696 | $2,613 |
| % Margin | 50.4% | 93.5% | 36.6% | 29.6% |
| R&D Expenses | $460 | $312 | $625 | $575 |
| G&A Expenses | $0 | $0 | $0 | $1,796 |
| SG&A Expenses | $1,664 | $1,376 | $2,101 | $1,796 |
| Sales & Mktg Exp. | $0 | $0 | $2,101 | $0 |
| Other Operating Expenses | $4 | $0 | $0 | $0 |
| Operating Expenses | $2,128 | $1,688 | $2,726 | $2,370 |
| Operating Income | -$1,137 | -$299 | -$30 | $243 |
| % Margin | -108.1% | -32.4% | -0.4% | 2.7% |
| Other Income/Exp. Net | $39 | $27 | -$4,773 | -$33 |
| Pre-Tax Income | -$1,559 | -$388 | -$4,803 | $209 |
| Tax Expense | $0 | -$13 | $0 | $437 |
| Net Income | -$1,112 | -$271 | -$4,803 | -$228 |
| % Margin | -105.7% | -29.3% | -65.2% | -2.6% |
| EPS | -0.007 | -0.002 | -0.03 | -0.002 |
| % Growth | -272.2% | 94% | -1,900% | – |
| EPS Diluted | -0.007 | -0.002 | -0.03 | -0.002 |
| Weighted Avg Shares Out | 165,815 | 148,223 | 148,223 | 148,223 |
| Weighted Avg Shares Out Dil | 165,815 | 148,223 | 148,223 | 148,223 |
| Supplemental Information | – | – | – | – |
| Interest Income | $39 | $54 | $66 | $0 |
| Interest Expense | $2 | $2 | $0 | $33 |
| Depreciation & Amortization | $27 | $78 | $89 | $90 |
| EBITDA | -$1,082 | -$5,312 | $59 | $332 |
| % Margin | -102.9% | -575.7% | 0.8% | 3.8% |